Animal Testing on the Outs?
In 2020, EPA’s New Approach Methods, also known as NAMs, was released with the incentive to reduce the use of vertebrate animal testing (US EPA NAMs). Based on new legislation, the US FDA will no longer need to require animal testing before human drug trials. Alternative methods for research and development are becoming more and more favorable not only to reduce animal testing but in cost-effectiveness as well. Check out the article here.
Waterborne Posters and Papers at SETAC Europe 36th Annual Meeting
SETAC Europe 36th Annual Meeting – May 17 to May 21, 2026 in Maastricht, the Netherlands April 23, 2026 |…
READ MORE
Evaluating Groundwater Exposure
Evaluating Groundwater Exposure April 22, 2026 | Field Studies | Patrick Holden, Waterborne Co-Founder As Waterborne approaches its 33rd anniversary, we…
READ MORE
EPA’s Proposed Rollback of Chemical Safety Protections: What It Means for Environmental Stewardship
EPA’s Proposed Rollback of Chemical Safety Protections: What It Means for Environmental Stewardship March 2, 2026 | Endangered Species |…
READ MORE
Waterborne kicks off 2026 at NAICC in Orlando, FL
Waterborne kicks off 2026 at NAICC in Orlando, FL March 2, 2026 | Waterborne News | Jennifer TraskLast month, the…
